CytomX Therapeutics Berita Eulerpool

CytomX Therapeutics Eulerpool News

CytomX Therapeutics Berita Saham

CytomX Therapeutics diawasi oleh banyak jurnalis dan investor di seluruh dunia. Berita terkini CytomX Therapeutics kami rangkum di sini.

• 9 September ·

  Yahoo
  CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors
• 9 September ·

  GlobeNewswire
  CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY?, in a Phase 1 Study in Patients with Solid Tumors
• 4 September ·

  Yahoo
  CytomX Therapeutics to Present at Upcoming September Investor Conferences
• 10 Agustus ·

  Yahoo
  CytomX Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
• 9 Agustus ·

  SeekingAlpha
  CytomX Therapeutics, Inc. (CTMX) Q2 2024 Earnings Call Transcript
• 9 Agustus ·

  TipRanks
  CytomX Therapeutics (CTMX) Gets a Buy from Wedbush
• 9 Agustus ·

  Seeking Alpha
  CytomX Therapeutics files $250M mixed securities shelf
• 9 Agustus ·

  TipRanks
  CytomX Therapeutics (CTMX) Receives a Buy from Barclays
• 8 Agustus ·

  Yahoo
  CytomX Therapeutics: Q2 Earnings Snapshot
• 8 Agustus ·

  Yahoo
  CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update